SGLT2 INHIBITION IN HEART FAILURE WITH A REDUCED EJECTION FRACTION: HOW MANY PATIENTS WOULD BENEFIT?

被引：1
|
作者：
Hooper, Jacquelyn [1 ]
Shaw, Steven [1 ]
Callan, Paul [1 ]
Williams, Simon [1 ]
机构：
[1] Wythenshawe Hosp, Manchester, Lancs, England
来源：
HEART | 2021年 / 107卷
关键词：
D O I：
10.1136/heartjnl-2021-BCS.147
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
150
引用
收藏
页码：A115 / A115
页数：1
相关论文
共 50 条
  • [21] Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fraction
    Docherty, Kieran F.
    McMurray, John J. V.
    Kalra, Paul R.
    Cleland, John G. F.
    Lang, Ninian N.
    Petrie, Mark C.
    Robertson, Michele
    Ford, Ian
    ESC HEART FAILURE, 2024, 11 (04): : 1875 - 1879
  • [22] UTILIZATION OF SGLT2 INHIBITORS IN UNITED STATES VETERANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
    Chiu, Leonard
    Park, Daniel
    Gupta, Deepak K.
    Matheny, Michael Edwin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 286 - 286
  • [23] Change in Diuretic Dose After Initiation of a SGLT2 Inhibitor in Patients with Heart Failure with Reduced Ejection Fraction
    Wildemann, R.
    Karalis, D. G.
    Mirachi, N.
    Thoma, B.
    D'Angelo, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S340 - S340
  • [24] Clinical Considerations for Use of SGLT2 Inhibitor Therapy in Patients with Heart Failure and Reduced Ejection Fraction: A Review
    Jhalani, Nisha B.
    ADVANCES IN THERAPY, 2022, 39 (08) : 3472 - 3487
  • [25] SGLT2 Inhibition in Heart Failure with a Preserved Ejection Fraction - A Win against a Formidable Foe
    Drazner, Mark H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16): : 1522 - 1524
  • [26] Heart Failure Preserved Ejection Fraction Patients Benefit From Heart Failure Reduced Ejection Fraction Guidelines
    Steahr, Gregg
    Kelly, Linda
    Moore, Meredith
    Hott, Brenda
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S73 - S74
  • [27] Eligibility and prescribing rates of SGLT2 inhibitors for ambulatory patients with heart failure and reduced ejection fraction in a multidisciplinary heart failure management programme
    Nadarajah, R.
    Younis, A.
    Aktaa, S.
    Gale, C. P.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [28] SGLT2 INHIBITOR PRESCRIPTION RATE FOR PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)
    Kim, Justin
    Chakrala, Teja
    Prakash, Roshni
    Ghaffar, Umar
    Patel, Jaymin
    Dass, Bhagwan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 404 - 404
  • [29] The Impact of SGLT2 Inhibitors on Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
    Starr, Jessica A.
    Pinner, Nathan A.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (05) : 506 - 513
  • [30] SGLT2 inhibitors in real-world patients with heart failure with preserved ejection fraction
    Tarantini, R.
    Vecchi, A. L.
    Matteo, F.
    De Ponti, R.
    Mortara, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 779 - 779
12345